David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 90,988 shares at $39.22 ($3.6M) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $3.6M RYTM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.22 | 45,494 | $1.8M | 50.0% |
| 2 | $39.22 | 45,494 | $1.8M | 50.0% |
| Total | $39.22 avg | 90,988 | $3.6M | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |